[{"Assets_0_Q2_USD":1247160000.0,"CommonStockSharesOutstanding_0_Q2_shares":66346248.0,"EarningsPerShareBasic_1_Q2_USD":-1.67,"EarningsPerShareBasic_2_Q2_USD":-2.22,"EarningsPerShareDiluted_1_Q2_USD":-1.67,"EarningsPerShareDiluted_2_Q2_USD":-2.22,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-152922000.0,"NetIncomeLoss_1_Q2_USD":-109267000.0,"NetIncomeLoss_2_Q2_USD":-144630000.0,"StockholdersEquity_0_Q2_USD":699047000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":65484000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":65060000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":65484000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":65060000.0,"Ticker":"SRPT","CIK":"873303","name":"SAREPTA THERAPEUTICS, INC.","OfficialName":"Sarepta Therapeutics Inc. Common Stock (DE)","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7117506934.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]